IRF3 and autoimmune disease: TTN regulates abnormal cGAS-STING signalling pathway activation by modulating the interaction between STING and IRF3, demonstrating significant therapeutic potential for autoimmune diseases and ALI mediated by the cGAS-STING pathway.